Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2006 2
2007 1
2008 3
2009 1
2011 1
2012 1
2013 1
2015 1
2016 1
2018 3
2019 2
2020 2
2022 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Spontaneous rupture of non-parasitic hepatic cyst.
Poggi G, Gatti C, Delmonte A, Teragni C, Bernardo G. Poggi G, et al. Among authors: teragni c. Int J Clin Pract. 2006 Jan;60(1):99-103. doi: 10.1111/j.1368-5031.2005.00655.x. Int J Clin Pract. 2006. PMID: 16409436 Review.
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study.
Quaquarini E, Sottotetti F, Agustoni F, Pozzi E, Malovini A, Teragni CM, Palumbo R, Saltalamacchia G, Tagliaferri B, Balletti E, Rinaldi P, Canino C, Pedrazzoli P, Bernardo A. Quaquarini E, et al. Among authors: teragni cm. J Pers Med. 2022 Apr 24;12(5):679. doi: 10.3390/jpm12050679. J Pers Med. 2022. PMID: 35629102 Free PMC article.
The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors.
Sottotetti F, Ferraris E, Tagliaferri B, Palumbo R, Quaquarini E, Teragni C, Balletti E, Leli C, Premoli A, Mollica L, Puglisi S, Sardi S, Malovini A, Pedrazzoli P, Bernardo A. Sottotetti F, et al. Among authors: teragni c. Drugs Context. 2022 Sep 5;11:2022-1-3. doi: 10.7573/dic.2022-1-3. eCollection 2022. Drugs Context. 2022. PMID: 36118250 Free PMC article.
Role of androgen receptor expression in early stage ER+/PgR-/HER2- breast cancer.
Tagliaferri B, Quaquarini E, Palumbo R, Balletti E, Presti D, Malovini A, Agozzino M, Teragni CM, Terzoni A, Bernardo A, Villani L, Sottotetti F. Tagliaferri B, et al. Among authors: teragni cm. Ther Adv Med Oncol. 2020 Sep 17;12:1758835920958355. doi: 10.1177/1758835920958355. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32994808 Free PMC article.
Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR+/HER2- breast cancer treated with CDK4/6 inhibitors and endocrine therapy.
Tagliaferri B, Mollica L, Palumbo R, Leli C, Malovini A, Terzaghi M, Quaquarini E, Teragni C, Maccarone S, Premoli A, Sottotetti F. Tagliaferri B, et al. Among authors: teragni c. Drugs Context. 2023 Jun 20;12:2023-1-7. doi: 10.7573/dic.2023-1-7. eCollection 2023. Drugs Context. 2023. PMID: 37378079 Free PMC article.
Perceived risk, illness perception and dispositional optimism related to COVID-19 among oncologic outpatients undergoing in-hospital treatments and healthy controls.
Gabanelli P, Monzani D, Fiabane E, Quaquarini E, Frascaroli M, Balletti E, Bernardo A, Teragni CM, Grossi F, Pravettoni G, Gorini A. Gabanelli P, et al. Among authors: teragni cm. Psychol Health. 2024 Mar-Apr;39(3):417-433. doi: 10.1080/08870446.2022.2065275. Epub 2022 Apr 17. Psychol Health. 2024. PMID: 35435083
Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy).
Quaquarini E, Saltalamacchia G, Presti D, Caldana G, Tibollo V, Malovini A, Palumbo R, Teragni CM, Balletti E, Mollica L, Biscaldi E, Frascaroli M, Bernardo A, Sottotetti F. Quaquarini E, et al. Among authors: teragni cm. Cancers (Basel). 2020 Oct 12;12(10):2941. doi: 10.3390/cancers12102941. Cancers (Basel). 2020. PMID: 33053782 Free PMC article.
Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR+/HER2- metastatic breast cancer: a prospective, monocentric study.
Palumbo R, Quaquarini E, Saltalamacchia G, Malovini A, Lapidari P, Tagliaferri B, Mollica L, Teragni CM, Barletta C, Locati LD, Sottotetti F. Palumbo R, et al. Among authors: teragni cm. Drugs Context. 2024 Feb 5;13:2023-7-5. doi: 10.7573/dic.2023-7-5. eCollection 2024. Drugs Context. 2024. PMID: 38332945 Free PMC article.
26 results